DiviDrip · CURX

CURX — Curanex Pharmaceuticals Inc

CURX is Curanex Pharmaceuticals Inc (Healthcare) — a non-dividend-paying stock. Trading at $5.05. Market cap: $7M. Capital Quality Rank: 32/100 — Stagnant mediocrity.

Stock snapshot

Price$5.05
Market cap$7M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)32 / 100 · Stagnant mediocrity
ROIC (TTM)-15.8%
Altman Z-score zoneSafe

About CURX

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Listed2025Employees6HQJericho, NYSectorHealthcareWebsitecuranexpharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside CURX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is CURX's current stock price?

CURX (Curanex Pharmaceuticals Inc) is currently trading at $5.05.

Does CURX pay a dividend?

CURX (Curanex Pharmaceuticals Inc) does not currently pay a regular dividend.

What is CURX's Capital Quality Rank?

CURX has a Capital Quality Rank of 32/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track CURX in DiviDrip

Add CURX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow